<DOC>
	<DOCNO>NCT00570739</DOCNO>
	<brief_summary>This 16-week double-blind , placebo-controlled ( colesevelam hydrochloride ( HCl ) ) study type 2 diabetic subject pre-diabetic subject . Diabetic participant also treat open label , background , metformin HCl . Two-hundred sixty subject type 2 diabetes ( T2DM ) 200 pre-diabetic subject plan enrol . Qualified subject T2DM randomize 1:1 receive metformin HCl plus colesevelam HCl metformin HCl plus placebo matching colesevelam HCl . Qualified pre-diabetic subject randomize 1:1 receive colesevelam HCl match placebo .</brief_summary>
	<brief_title>Effects Metformin Hydrochloride ( HCl ) Combination With Colesevelam HCl , Compared Metformin HCl Alone , Patients With Type 2 Diabetes Mellitus Effects Colesevelam HCl Lipids Glucose Pre-diabetic Patients .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Age 18 79 year , inclusive . HbA1C range great equal 6.5 percent small equal 10.0 percent , enrol T2DM cohort . 2hour post 75 g OGTT glucose level range : great equal 200 mg/dL enrol T2DM cohort , great equal 140 200 mg/dL enrol prediabetes cohort . FPG level range : great equal 126 mg/dL enrol T2DM cohort , great equal 110 small equal 125 mg/dL enrol prediabetes cohort . LDLC level great equal 100 mg/dL . Drugna√Øve , define never receive treatment T2DM receive antidiabetic drug therapy 3 month prior screen visit . Previous diagnosis : T2DM prediabetes , enrol respective cohort , CHD , CVD , and/or primary hypercholesterolemia + BMI great equal 25 mg/kg2 screen T2DM prediabetes . Understanding study procedure agreement participate study give write informed consent screen visit . Women may enrol 3 follow criterion ( addition criterion ) meet : They pregnant ( woman childbearing potential must negative serum pregnancy test [ serum beta human chorionic gonadotropin ) ] screen visit ) ; They breastfeed ; They plan become pregnant study . In addition criterion , woman must also meet 1 follow 3 criterion enrol : They postmenopausal least 1 year ; They childbearing potential practice 1 follow method birth control throughout study : oral , injectable , implantable hormonal contraceptive ; intrauterine device ; diaphragm plus spermicide ; female condom plus spermicide . Methods contraception acceptable partner 's use condoms partner 's vasectomy . History type 1 diabetes and/or history acute chronic metabolic acidosis , include diabetic ketoacidosis . History chronic ( require daily great 2 month ) use insulin therapy , except treatment gestational diabetes . Current prior ( within past 3 month ) treatment oral antidiabetic drug . Current prior ( within past 3 month ) treatment colesevelam HCl ( WelChol ) , colestipol , colestimide , cholestyramine . History dysphagia , swallow disorder , intestinal motility disorder . Any serious disorder , include pulmonary , hepatic , gastrointestinal ( include clinically significant malabsorption ) , uncontrolled endocrine/metabolic , hematologic/oncologic ( within last 5 year ) , neurologic , psychiatric disease , would interfere conduct study interpretation data . Acute coronary syndrome ( eg , myocardial infarction unstable angina ) , coronary intervention ( coronary artery bypass graft percutaneous transluminal coronary angioplasty similar procedure ) , congestive heart failure ( require pharmacological treatment ) , transient ischemic attack within 3 month screen visit . History pancreatitis . History acquire immune deficiency syndrome human immunodeficiency virus . History drug alcohol abuse within past 2 year . Hospitalization cause within 14 day prior screen visit . History allergic toxic response colesevelam HCl component . Known hypersensitivity metformin HCl . Serum TG great equal 500 mg/dL . Body mass index ( BMI ) great 40 kg/m2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Colesevelam</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Pre-diabetes</keyword>
	<keyword>Metformin</keyword>
</DOC>